Negara: Selandia Baru
Bahasa: Inggris
Sumber: Medsafe (Medicines Safety Authority)
Cefepime dihydrochloride monohydrate 575.9mg equivalent to 500 mg cefepime free base;
Viatris Limited
Cefepime dihydrochloride monohydrate 575.9 mg (equivalent to 500 mg cefepime free base)
500 mg
Powder for injection
Active: Cefepime dihydrochloride monohydrate 575.9mg equivalent to 500 mg cefepime free base Excipient: Arginine
Vial, glass, single dose, Type 1 clear glass vial with grey bromo butyl rubber stopper, 500 mg
Prescription
Prescription
Aurobindo Pharma Limited
CEFEPIME Mylan is indicated in adults for the treatment of the infections listed below when caused by susceptible bacteria. · Lower respiratory tract infections, including pneumonia and bronchitis. · Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. · Skin and skin structure infections. · Septicaemia. · Intra-abdominal infections, including peritonitis and biliary tract infections. · Empiric treatment of febrile neutropenia.
Package - Contents - Shelf Life: Vial, glass, single dose, Type 1 clear glass vial with grey bromo butyl rubber stopper - 500 mg - 2 years from date of manufacture stored at or below 25°C protect from light 24 hours reconstituted stored at or below 25°C protect from light 168 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) protect from light
2009-06-17